Correction to: Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts

Affiliations

Jeonghyeon Moon: Lab of Translational ImmunoMedicine, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea
Seon-yeong Lee: Rheumatism Research Center, College of Medicine, Catholic Research Institute of Medical Science, The Catholic University of Korea
Jeong Won Choi: Rheumatism Research Center, College of Medicine, Catholic Research Institute of Medical Science, The Catholic University of Korea
A. Ram Lee: Rheumatism Research Center, College of Medicine, Catholic Research Institute of Medical Science, The Catholic University of Korea
Jin Hee Yoo: Rheumatism Research Center, College of Medicine, Catholic Research Institute of Medical Science, The Catholic University of Korea
Su-Jin Moon: Divison of Rheumatology, Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea
Sung-Hwan Park: Division of Rheumatology, Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea
Mi-La Cho: Lab of Translational ImmunoMedicine, Catholic Research Institute of Medical Science, College of Medicine, The Catholic University of Korea

Abstract

An amendment to this paper has been published and can be accessed via the original article.